Literature DB >> 36267331

Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy.

Mariel G Kozberg1,2, Irvin Yi3, Whitney M Freeze4,5, Corinne A Auger1, Ashley A Scherlek1, Steven M Greenberg2, Susanne J van Veluw1,2,4.   

Abstract

Cerebral amyloid angiopathy is a small vessel disease associated with cortical microbleeds and lobar intracerebral haemorrhage due to amyloid-β deposition in the walls of leptomeningeal and cortical arterioles. The mechanisms of cerebral amyloid angiopathy-related haemorrhage remain largely unknown. Recent work has demonstrated that ruptured blood vessels have limited (or no) amyloid-β at the site of bleeding and evidence of local vascular remodelling. We hypothesized that blood-brain barrier leakage and perivascular inflammation may be involved in this remodelling process. This study examined cortical arterioles at various stages of cerebral amyloid angiopathy-related vascular pathology (without evidence of microhaemorrhage) in autopsy tissue from seven cases with definite cerebral amyloid angiopathy. We included temporo-occipital sections with microbleeds guided by ex vivo MRI from two cases with severe cerebral amyloid angiopathy and systematically sampled occipital sections from five consecutive cases with varying cerebral amyloid angiopathy severity. Haematoxylin and eosin stains and immunohistochemistry against amyloid-β, fibrin(ogen), smooth muscle actin, reactive astrocytes (glial fibrillary acidic protein) and activated microglia (cluster of differentiation 68) were performed. Arterioles were graded using a previously proposed scale of individual vessel cerebral amyloid angiopathy severity, and a blinded assessment for blood-brain barrier leakage, smooth muscle actin and perivascular inflammation was performed. Blood-brain barrier leakage and smooth muscle actin loss were observed in significantly more vessels with mild amyloid-β deposition (Grade 1 vessels; P = 0.044 and P = 0.012, respectively) as compared to vessels with no amyloid-β (Grade 0), and blood-brain barrier leakage was observed in 100% of vessels with evidence of vessel remodelling (Grades 3 and 4). Perivascular inflammation in the form of reactive astrocytes and activated microglia was observed predominantly surrounding arterioles at later stages of vessel pathology (Grades 2-4) and consistently around vessels with the same morphological features as ruptured vessel segments (Grade 4). These findings suggest a role for blood-brain barrier leakage and perivascular inflammation leading to arteriolar remodelling and haemorrhage in cerebral amyloid angiopathy, with early blood-brain barrier leakage as a potential trigger for subsequent perivascular inflammation.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  blood–brain barrier leakage; cerebral amyloid angiopathy; microbleeds; perivascular inflammation

Year:  2022        PMID: 36267331      PMCID: PMC9576155          DOI: 10.1093/braincomms/fcac245

Source DB:  PubMed          Journal:  Brain Commun        ISSN: 2632-1297


  35 in total

1.  Cerebral amyloid angiopathy related inflammation: three case reports and a review.

Authors:  Kong Khi Chung; Neil E Anderson; David Hutchinson; Beth Synek; P Alan Barber
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

2.  Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Authors:  Elisabeth Tarkowski; Razao Issa; Magnus Sjögren; Anders Wallin; Kaj Blennow; Andrej Tarkowski; Pat Kumar
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

3.  Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.

Authors:  Axel Montagne; Angeliki M Nikolakopoulou; Zhen Zhao; Abhay P Sagare; Gabriel Si; Divna Lazic; Samuel R Barnes; Madelaine Daianu; Anita Ramanathan; Ariel Go; Erica J Lawson; Yaoming Wang; William J Mack; Paul M Thompson; Julie A Schneider; Jobin Varkey; Ralf Langen; Eric Mullins; Russell E Jacobs; Berislav V Zlokovic
Journal:  Nat Med       Date:  2018-02-05       Impact factor: 53.440

4.  Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy.

Authors:  S M Greenberg; J P Vonsattel
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

5.  MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.

Authors:  Mar Hernandez-Guillamon; Elena Martinez-Saez; Pilar Delgado; Sophie Domingues-Montanari; Cristina Boada; Anna Penalba; Mercè Boada; Jorge Pagola; Olga Maisterra; David Rodriguez-Luna; Carlos A Molina; Alex Rovira; José Alvarez-Sabin; Arantxa Ortega-Aznar; Joan Montaner
Journal:  Brain Pathol       Date:  2011-09-15       Impact factor: 6.508

6.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.

Authors:  Jonathan Rosand; Mark H Eckman; Katherine A Knudsen; Daniel E Singer; Steven M Greenberg
Journal:  Arch Intern Med       Date:  2004-04-26

7.  Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy.

Authors:  Whitney M Freeze; Brian J Bacskai; Matthew P Frosch; Heidi I L Jacobs; Walter H Backes; Steven M Greenberg; Susanne J van Veluw
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

8.  Different microvascular alterations underlie microbleeds and microinfarcts.

Authors:  Susanne J van Veluw; Ashley A Scherlek; Whitney M Freeze; Annemieke Ter Telgte; Andre J van der Kouwe; Brian J Bacskai; Matthew P Frosch; Steven M Greenberg
Journal:  Ann Neurol       Date:  2019-06-14       Impact factor: 10.422

9.  Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy.

Authors:  Susanne J van Veluw; Hugo J Kuijf; Andreas Charidimou; Anand Viswanathan; Geert Jan Biessels; Annemieke J M Rozemuller; Matthew P Frosch; Steven M Greenberg
Journal:  Acta Neuropathol       Date:  2016-10-22       Impact factor: 17.088

Review 10.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.

Authors:  Mark A Petersen; Jae Kyu Ryu; Katerina Akassoglou
Journal:  Nat Rev Neurosci       Date:  2018-04-05       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.